Friday, July 10, 2026

pharma · Sepsis · Tumor, Solid

Sichuan Kelun Pharmaceutical

Sichuan Provincial People's is a pharma organization headquartered in CN. Primary therapeutic focus areas include Sepsis, Tumor, Solid, Carcinoma, Non-Small-Cell Lung, Advanced Solid Tumors. NovaPharmaNews links 4 clinic

CN HQ
375 Employees
NMPA registrant Type
Company details
Status
Public
HQ
CN
Employees
375
Programs
4
Drugs
6
Patents
0
Clinical program

rSIFN-co

Phase 1 · small molecule · Carcinoma, Non-Small-Cell Lung

rSIFN-co for Carcinoma, Non-Small-Cell Lung is a Phase 1 program (small_molecule) at Sichuan Provincial People's Hospital with 1 ClinicalTrials.gov record(s).

Internal code rSIFN-01

Full intelligence profile for this program is being prepared.

At a glance

Sponsor
Sichuan Provincial People's Hospital
Phase
Phase 1
Modality
small_molecule
Indication
Carcinoma, Non-Small-Cell Lung
Status
completed
Trials
1

Clinical trials